Effects of SGLT2 Inhibitors with and without Metformin in High-Risk, Treatment-Naïve Patients with Diabetes
CY Huang, JK Lee - Journal of Clinical Medicine, 2024 - mdpi.com
Background: Contemporary evidence supports the cardiovascular and renal benefits of
sodium-glucose co-transporter-2 inhibitors (SGLT2is) in patients with diabetes. While …
sodium-glucose co-transporter-2 inhibitors (SGLT2is) in patients with diabetes. While …